 Idoxuridine is mainly used topically to treat herpes simplex keratitis.Epithelial lesions, especially initial attacks presenting with a dendritic ulcer, are most responsive to therapy, while infection with stromal involvement are less responsive.Idoxuridine is ineffective against herpes simplex virus type 2 and varicella-zoster.